Prof. Dr. VEHBİ ERÇOLAK
- Yöksis ID 116772
- Researcher ID
- ORCID ID 0000-0003-1014-1694
- Scopus ID
- Scholar ID
- E-posta vehbiercolak@mersin.edu.tr
- Dahili Telefon
Birim
TIP FAKÜLTESİ
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Tıbbi Onkoloji (İç Hastalıkları)
Tıbbi Onkoloji (İç Hastalıkları)
Son 5 Makale
Real-world comparison of cabozantinib and sunitinib inadvanced non-clear cell renal cell carcinoma: A multicenterstudy by the Turkish Oncology Group
International journal of cancer, vol. , no. , pp. – Link 2026
OUR CHEMOTHERAPY RESULTS IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER
Sabuncuoglu Serefeddin Health Sciences, vol. 7, no. , pp. – Link 2025
Progressive Disseminated Adenoid Cystic Carcinoma as shown by follow up 18Flourine Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: a rare case report
Molecular Oncologic Imaging, vol. 5, no. 1, pp. 17–20 Link 2025
F-18 Fluorodeoxyglucose and Ga-68 Peptide Receptor Imaging of Cervix Mixed Large Cell Carcinoma Patient Presented With Brain Metastasis
Molecular Oncologic Imaging, vol. 5, no. 1, pp. 21–23 Link 2025
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
MEDICINA-LITHUANIA, vol. 61, no. 11, pp. 1966– Link 2025
International journal of cancer, vol. , no. , pp. – Link 2026
OUR CHEMOTHERAPY RESULTS IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER
Sabuncuoglu Serefeddin Health Sciences, vol. 7, no. , pp. – Link 2025
Progressive Disseminated Adenoid Cystic Carcinoma as shown by follow up 18Flourine Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: a rare case report
Molecular Oncologic Imaging, vol. 5, no. 1, pp. 17–20 Link 2025
F-18 Fluorodeoxyglucose and Ga-68 Peptide Receptor Imaging of Cervix Mixed Large Cell Carcinoma Patient Presented With Brain Metastasis
Molecular Oncologic Imaging, vol. 5, no. 1, pp. 21–23 Link 2025
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
MEDICINA-LITHUANIA, vol. 61, no. 11, pp. 1966– Link 2025
Son 5 Bildiri
The Role of lncRNA H19 in the Resistance of Ovarian Cancer Cells to Cisplatin Therapy
6th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2023) (11.10.2023 - 13.10.2023) Link 2023
LACK OF ASSOCIATION BETWEEN VARIATIONS ON TOLL-LIKE RECEPTOR GENES AND BREAST CANCER IN MERSİN, SOUTHERN TURKEY
13th International Symposıum on Pharmaceutical Sciences (22.06.2021 - 25.06.2021) 2021
The prognostic and predictive value of primary tumor sidedness in the mCRC p
ESMO 20th World Congress on Gastrointestinal Cancer 20–23 June 2018, Barcelona, Spain (19.10.2018 - ) 2018
S-062 Bazal hücreli kanser tedavisinde oral kemoterapötik vismodegib kullanımı hakkında tecrübelerimiz
Türk Plastik, Rekonstrüktif ve Estetik Cerrahi Derneği, 40. Ulusal Kurultayı (17.10.2018 - 21.10.2018) 2018
Effectiveness of vandetanib treatment in medullary thyroid cancer. single center experience
2.ulusal immunoterapi ve onkoloji kongresi (31.10.2018 - 04.11.2018) 2018
6th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2023) (11.10.2023 - 13.10.2023) Link 2023
LACK OF ASSOCIATION BETWEEN VARIATIONS ON TOLL-LIKE RECEPTOR GENES AND BREAST CANCER IN MERSİN, SOUTHERN TURKEY
13th International Symposıum on Pharmaceutical Sciences (22.06.2021 - 25.06.2021) 2021
The prognostic and predictive value of primary tumor sidedness in the mCRC p
ESMO 20th World Congress on Gastrointestinal Cancer 20–23 June 2018, Barcelona, Spain (19.10.2018 - ) 2018
S-062 Bazal hücreli kanser tedavisinde oral kemoterapötik vismodegib kullanımı hakkında tecrübelerimiz
Türk Plastik, Rekonstrüktif ve Estetik Cerrahi Derneği, 40. Ulusal Kurultayı (17.10.2018 - 21.10.2018) 2018
Effectiveness of vandetanib treatment in medullary thyroid cancer. single center experience
2.ulusal immunoterapi ve onkoloji kongresi (31.10.2018 - 04.11.2018) 2018